Dr. Fikre Woldeamlak Degefu, MD

Dr. Degefu practices at TidalHealth Atlantic in Berlin, Maryland, part of TidalHealth Peninsula Regional.

Dr. Degefu's NPI, 1649402876, was assigned on August 21, 2009. Dr. Degefu holds Virginia license 0101252049.

Dr. Degefu's primary practice is TidalHealth Atlantic, at 9733 Healthway Drive, Berlin, MD 21811 in Worcester County. The practice phone is (410) 641-1100.

Dr. Degefu's primary practice is TidalHealth Atlantic in Berlin, Maryland, part of TidalHealth Peninsula Regional. Dr. Degefu is also affiliated with Carilion Roanoke Memorial Hospital. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Dr. Degefu to 3 more hospitals, 11 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Degefu practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Degefu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Degefu's licenses on file in 2 states: Virginia and Michigan.

CMS data shows 923 Medicare services from Dr. Degefu across 4 procedure codes in 2024, for 281 Medicare patients. Medicare paid $61,202 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 281 Medicare patients who saw Dr. Degefu in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Degefu's median patient age at 75, with 49% women.

In 2024, Dr. Degefu wrote 111 Medicare Part D claims for 55 patients. 85% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $83 in total drug cost. In 2018, CMS named 11 claims across 1 drug.

Dr. Degefu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 129 general payments to Dr. Degefu from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $592.